XML 98 R49.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The income tax expense (benefit) in 2024 and 2023 consisted of the following:

Year Ended December 31,
20242023
Current
Federal$(294)$— 
State58 — 
(236)— 
Deferred
Federal1,868 400 
State866 (16)
2,734 384 
Total income tax expense (benefit)$2,498 $384 
Schedule of Effective Income Tax Rate Reconciliation
The differences between the federal tax rate and the Company’s effective tax rate for the years ended December 31, 2024 and 2023 are as follows:

Year Ended December 31,
20242023
Federal statutory income tax rate21.00 %21.00 %
State taxes, net of federal benefit3.181.01
State rate change-1.61-0.05
Revisions to prior years' estimates2.54-0.38
Nontaxable passthrough LLC income-9.94-10.41
Change in valuation allowance-25.67-6.93
Other0.300.00
Transaction related expenses0.30-4.57
Revaluation of warrants-0.25-0.29
Effective tax rate(10.15)%(0.62)%
Schedule of Deferred Tax Assets and Liabilities
Components of the net deferred tax assets and liabilities at December 31, 2024 and 2023 are as follows:

As of December 31
20242023
Deferred tax assets
Investment in partnership$16,026 $9,337 
Net operating loss carryforwards13,680 10,092 
Accrued expenses224 160 
Start-up costs1,242 748 
Interest expense limitation carryforward341 — 
Stock compensation1,098 — 
Gross deferred tax assets32,611 20,337 
Valuation allowance(32,611)(17,443)
Net deferred tax assets (after valuation allowance)— 2,894